LifeMD, Inc. (LFMD) Stock Forecast
Data as of May 2, 2026Healthcare · Current price $4.99 (+6.52%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Mar 12, 2026 | Ilya Zubkov | Loop Capital Markets | $10.00 | +100.6% |
| Nov 24, 2025 | Ilya Zubkov | Loop Capital Markets | $8.00 | +60.5% |
| Nov 19, 2025 | Steven Valiquette | Mizuho Securities | $6.00 | +20.4% |
| Nov 19, 2025 | Scott Schoenhaus | KeyBanc | $8.00 | +60.5% |
| Jul 10, 2025 | Brooks O'Neil | Lake Street | $18.00 | +261.1% |
| Mar 12, 2025 | Yi Chen | H.C. Wainwright | $14.00 | +180.8% |
| Jan 8, 2025 | Scott Schoenhaus | KeyBanc | $7.00 | +40.4% |
| Dec 10, 2024 | Brooks O'Neil | Lake Street | $12.00 | +140.7% |
| Oct 14, 2024 | Kyle Bauser | BTIG | $12.00 | +140.7% |
| Jun 4, 2024 | Steve Dechert | KeyBanc | $12.00 | +140.7% |
| Apr 23, 2024 | David Larsen | BTIG | $14.00 | +180.8% |
Top Analysts Covering LFMD
LFMD vs Sector & Market
| Metric | LFMD | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.08 | 2.24 | 2.41 |
| Analyst Count | 12 | 8 | 18 |
| Target Upside | +70.5% | +1150.2% | +14.9% |
| P/E Ratio | -35.51 | 6.90 | 31.19 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $222M | $224M | $225M | 6 |
| 2027-03-31 | $58M | $61M | $62M | 3 |
| 2027-06-30 | $62M | $65M | $67M | 2 |
| 2027-09-30 | $65M | $68M | $70M | 2 |
| 2027-12-31 | $69M | $72M | $74M | 3 |
| 2028-03-31 | $65M | $68M | $70M | 2 |
| 2028-06-30 | $65M | $68M | $70M | 1 |
| 2028-09-30 | $67M | $70M | $72M | 1 |
| 2028-12-31 | $69M | $72M | $74M | 2 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $-6.65 | $-0.20 | $6.24 | 3 |
| 2027-03-31 | $0.01 | $0.01 | $0.01 | 1 |
| 2027-06-30 | $0.02 | $0.02 | $0.02 | 1 |
| 2027-09-30 | $0.05 | $0.05 | $0.06 | 1 |
| 2027-12-31 | $0.05 | $0.06 | $0.06 | 1 |
| 2028-03-31 | $0.00 | $0.00 | $0.00 | 1 |
| 2028-06-30 | $0.00 | $0.00 | $0.00 | 1 |
| 2028-09-30 | $0.00 | $0.00 | $0.00 | 1 |
| 2028-12-31 | $0.00 | $0.00 | $0.00 | 1 |
Frequently Asked Questions
What is the analyst consensus for LFMD?
The consensus among 12 analysts covering LifeMD, Inc. (LFMD) is Buy with an average price target of $8.50.
What is the highest price target for LFMD?
The highest price target for LFMD is $18.00, set by Brooks O'Neil at Lake Street on 2025-07-10.
What is the lowest price target for LFMD?
The lowest price target for LFMD is $6.00, set by Steven Valiquette at Mizuho Securities on 2025-11-19.
How many analysts cover LFMD?
12 analysts have issued ratings for LifeMD, Inc. in the past 12 months.
Is LFMD a buy or sell right now?
Based on 12 analyst ratings, LFMD has a consensus rating of Buy (2.08/5) with a +70.5% upside to the consensus target of $8.50.
What are the earnings estimates for LFMD?
Analysts estimate LFMD will report EPS of $-0.20 for the period ending 2026-12-31, with revenue estimated at $224M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.